Ozempic and the Microbiome: Effects & Gut Health Guide
Ozempic (semaglutide) has reshaped how we think about weight management and type 2 diabetes treatment, but its effects extend well beyond appetite and blood sugar. Emerging research shows that this GLP-1 receptor agonist significantly alters the composition and diversity of the gut microbiome—the trillions of bacteria, fungi, and other microorganisms living in your digestive tract. Understanding the relationship between Ozempic and the microbiome matters because these microbial shifts may influence everything from how well the medication works to the gastrointestinal side effects many people experience. This guide translates the latest science into clear, practical information, walking you through what the research shows, what it means for your health, and evidence-informed steps you can take to support your gut while on treatment.
What is the Gut Microbiome? A Quick Overview
Your gut microbiome is the vast community of microorganisms—primarily bacteria, but also fungi, viruses, and archaea—that colonize your gastrointestinal tract. These microbes number in the tens of trillions and collectively carry more genetic material than the human genome itself. Far from passive passengers, they function almost like an additional organ, participating in digestion, producing vitamins, training the immune system, and communicating with the brain through what scientists call the gut-brain axis.
The microbiome begins to establish itself at birth and evolves throughout life in response to diet, environment, medications, stress, illness, and age. No two people share an identical microbiome, which helps explain why individuals can respond very differently to the same foods, infections, or medications.
Key Functions of a Healthy Microbiome
- Digestion and nutrient extraction: Certain gut bacteria ferment dietary fibers that human enzymes cannot break down, producing short-chain fatty acids (SCFAs) such as butyrate, propionate, and acetate. These compounds nourish the intestinal lining and influence metabolism.
- Immune function: The gut houses a large proportion of the body's immune cells. Microbes help educate and regulate immune responses, maintaining a balance between tolerance and defense.
- Metabolic health: Gut bacteria influence how the body processes glucose and fats, affecting insulin sensitivity and energy storage.
- Gut-brain communication: The gut-brain axis involves bidirectional signaling through the vagus nerve, immune molecules, and microbial metabolites that can influence mood, cognition, and appetite regulation.
- Barrier protection: A healthy microbial community helps maintain the intestinal barrier, preventing harmful substances from leaking into the bloodstream.
Microbial Diversity and Dysbiosis
Microbial diversity—the variety and balance of species present—is often used as a marker of gut health. Generally, greater diversity is associated with better resilience and metabolic function, though the relationship is complex and not fully understood. When this balance is disrupted—a state called dysbiosis—it has been linked with conditions ranging from inflammatory bowel disease to obesity and insulin resistance. However, dysbiosis is not a single definable state, and its role in disease is an area of active investigation rather than a settled fact.
Understanding these fundamentals sets the stage for exploring how a medication like Ozempic can ripple through this intricate ecosystem.
How Ozempic (Semaglutide) Works: Beyond Weight Loss
Ozempic belongs to a class of medications called GLP-1 receptor agonists. It mimics glucagon-like peptide-1, a hormone your gut naturally releases after eating. By binding to GLP-1 receptors throughout the body, semaglutide triggers several effects that collectively improve blood sugar control and promote weight loss.
Primary Mechanisms
- Slowed gastric emptying: Semaglutide slows the rate at which food leaves the stomach, prolonging feelings of fullness and reducing appetite.
- Appetite regulation: It acts on appetite centers in the hypothalamus to reduce hunger and food cravings.
- Enhanced insulin secretion: It stimulates the pancreas to release insulin in a glucose-dependent manner, improving blood sugar control.
- Reduced glucagon release: It suppresses glucagon, a hormone that raises blood sugar, further aiding glycemic control.
Systemic Effects Relevant to the Gut
Beyond these well-established actions, GLP-1 receptor agonists exert broader effects. They may reduce systemic inflammation, influence the composition of bile acids, and alter the environment within the gastrointestinal tract. Because gastric emptying is slowed, the gut becomes a different habitat—one where food lingers longer, pH may shift, and nutrient availability to microbes changes. These environmental changes are precisely the kind of factors that can reshape microbial communities, providing a plausible biological pathway for the microbiome alterations observed in research.
It is also worth noting that GLP-1 receptors are expressed in various tissues, including the gut itself, suggesting that semaglutide may have direct effects on intestinal cells and, indirectly, on the microbes that interact with them.
Ozempic and Gut Bacteria: What the Research Shows
The relationship between semaglutide and the gut microbiome has become an active area of research, particularly since 2024. Studies in both humans and animal models have consistently found that semaglutide treatment is associated with notable shifts in gut microbiota composition. These changes are not uniform across all studies, and results vary depending on the population studied, baseline microbiome, diet, and duration of treatment. Still, some patterns have begun to emerge.
Changes in Microbial Diversity
One of the most consistent findings in recent clinical studies is a reduction in overall microbial diversity during semaglutide treatment. A 2024 study published in Nature Scientific Reports followed patients with type 2 diabetes and observed measurable declines in species richness and evenness after several months on semaglutide. This finding has been replicated in other small human trials, though not universally.
Reduced diversity might sound alarming, but the picture is nuanced. Diversity is not a straightforward proxy for health; some shifts in diversity reflect the gut adjusting to a new metabolic state. What matters more is which bacteria change and what those changes mean for the host. Researchers are still working to determine whether reduced diversity on semaglutide is transient, long-lasting, or clinically meaningful.
Increases in Specific Beneficial Bacteria
Alongside diversity changes, several studies have reported increases in bacteria that are generally considered beneficial for metabolic health:
- Akkermansia muciniphila: This bacterium is a standout in the literature. It lives in the mucus layer of the gut, helps maintain the intestinal barrier, and has been linked to improved insulin sensitivity and reduced inflammation. Multiple studies have reported an increase in Akkermansia abundance in both animal models and humans treated with semaglutide. Some researchers have suggested this could be one mechanism through which the drug exerts its metabolic benefits beyond appetite suppression.
- Bacteroides: Certain species within the Bacteroides genus, which are involved in carbohydrate metabolism and SCFA production, have shown increased abundance in some studies.
- Ruminococcus: Some Ruminococcus species, known for fiber fermentation and butyrate production, have also been observed to increase in certain cohorts, though findings are mixed.
It is important to emphasize that these are associations observed in research settings. They do not prove that these bacterial changes cause improved weight loss or better glucose control. The direction of causality—if any exists—remains under investigation.
View example recommendations from the InnerBuddies platform Preview the nutrition, supplement, food diary and food recipe platform recommendations that InnerBuddies can generate based on your gut microbiome testDecreases in Other Bacterial Populations
Some studies have reported reductions in bacterial groups associated with inflammation and metabolic dysfunction, which could theoretically be beneficial. Conversely, other findings have noted decreases in bacteria involved in normal fermentation processes, raising questions about whether the microbiome changes are uniformly positive. Most studies are small, and meta-analyses remain limited. The heterogeneity in study designs, populations, and sequencing methods makes drawing firm conclusions challenging.
What About Animal Studies?
Rodent studies have provided mechanistic clues. In mice treated with semaglutide, researchers have observed shifts in the ratio of Firmicutes to Bacteroidetes, changes in bile acid metabolism, and altered production of SCFAs. Transplanting the microbiota from semaglutide-treated mice into untreated mice has, in some experiments, produced modest metabolic improvements—suggesting that the microbiome may mediate some of the drug's effects. However, animal findings do not always translate to humans, and this remains an area of active research.
Potential Benefits of a Changing Microbiome on Metabolism and Health
The changes that semaglutide induces in the gut microbiome are not merely incidental. Emerging evidence suggests they may contribute to—or at least reinforce—some of the medication's therapeutic effects. Here is a closer look at the potential downstream benefits.
Strengthened Intestinal Barrier
Akkermansia muciniphila and certain SCFA-producing bacteria are known to support the intestinal barrier by promoting mucus production and tight junction integrity. A stronger barrier reduces the translocation of bacterial endotoxins like lipopolysaccharide (LPS) into the bloodstream—a phenomenon linked to low-grade inflammation and insulin resistance. By fostering these bacteria, semaglutide may help tighten the gut lining, which could theoretically enhance metabolic health and reduce inflammation.
Reduced Systemic Inflammation
Chronic low-grade inflammation is a hallmark of obesity and type 2 diabetes. SCFAs like butyrate have anti-inflammatory properties, and increased Akkermansia abundance has been associated with lower inflammatory markers in several studies. If semaglutide promotes these microbial changes, it may contribute to an overall reduction in inflammatory tone, which is beneficial for metabolic and cardiovascular health.
Improved Metabolic Signaling
Gut bacteria influence host metabolism through multiple pathways: SCFA production, bile acid modification, and regulation of gut hormones. Some research suggests that the microbiome shifts induced by semaglutide may improve insulin sensitivity and glucose handling. However, teasing apart the direct effects of the drug from microbiome-mediated effects is difficult, and more research is needed.
2-minute self-check Is a gut microbiome test useful for you? Answer a few quick questions and find out if a microbiome test is actually useful for you. ✔ Takes 2 minutes ✔ Based on your symptoms & lifestyle ✔ Clear yes/no recommendation Check if a test is right for me →Possible Effects on Appetite and the Gut-Brain Axis
The gut-brain axis is a two-way communication system linking the digestive tract and the central nervous system. Gut microbes can influence appetite-regulating hormones and neural signaling. While semaglutide's primary appetite effects are mediated through GLP-1 receptors, it is plausible that microbiome changes—particularly in SCFA-producing bacteria—may have complementary effects on satiety and food intake. This remains an intriguing hypothesis rather than an established mechanism.
Potential Risks: GI Side Effects and Reduced Diversity
Any discussion of Ozempic and gut health must address the challenges as well as the benefits. Semaglutide is well known for its gastrointestinal side effects, and changes in the microbiome may be intertwined with these symptoms.
Common GI Side Effects
Nausea, vomiting, diarrhea, and constipation are among the most frequently reported side effects of semaglutide. These occur because the medication slows gastric emptying and alters gut motility, changing how food and fluids move through the digestive tract. Nausea, in particular, affects a substantial proportion of users and can be dose-limiting.
These symptoms are not caused by the microbiome per se, but the altered gut environment—slower transit, changed nutrient availability—may influence microbial communities, which in turn could exacerbate discomfort. For example, slower transit can promote bacterial overgrowth in the small intestine, leading to bloating or changes in stool patterns.
Reduced Microbial Diversity: A Concern?
The observation that semaglutide may reduce microbial diversity has raised questions among researchers and patients alike. Diversity is often viewed as a marker of gut health and resilience, and several chronic conditions—including inflammatory bowel disease and obesity—are associated with lower diversity. But the relationship is not straightforward.
Reduced diversity on semaglutide may reflect a shift toward a more specialized microbiome suited to the altered metabolic and digestive environment—not necessarily a harmful change. Short-term reductions in diversity are not inherently dangerous, and the clinical significance of these shifts has not been established. What matters more is long-term observation: do these changes persist after stopping the medication, and do they carry any health consequences? These are open questions that longitudinal studies are just beginning to address.
Gastroparesis and Severe Complications
In rare cases, semaglutide has been associated with gastroparesis—delayed stomach emptying severe enough to cause persistent nausea, vomiting, and abdominal pain. This is distinct from the mild slowing of gastric emptying that is part of the drug's mechanism. Gastroparesis is a serious condition requiring medical evaluation. There is no evidence that the drug causes permanent structural damage to the stomach or gut, but symptoms should always be discussed with a healthcare provider.
Become a member of the InnerBuddies community Perform a gut microbiome test every couple of months and view your progress while following-up on our recommendationsThe Limitations of Current Research
It is essential to keep the limitations of existing research in mind. Most human studies on semaglutide and the microbiome are small, observational, and short-term. Microbiome analysis methods vary widely across studies, making direct comparisons difficult. Dietary changes—which often accompany weight loss—can independently alter the microbiome, confounding results. Randomized controlled trials with long-term follow-up and standardized microbiome sequencing are needed to draw firmer conclusions. Anyone interpreting microbiome findings should understand that correlation does not equal causation, and many of the observed changes are subtle.
Practical Strategies to Support Your Gut While on Ozempic
Regardless of how semaglutide reshapes your microbiome, there is a lot you can do to support gut health during treatment. The following strategies are grounded in general principles of gut health and are generally safe for people taking GLP-1 receptor agonists. Always discuss major dietary changes or supplements with your healthcare provider, especially if you have underlying conditions or are taking other medications.
1. Prioritize Fiber-Rich Foods
Dietary fiber is the primary fuel for beneficial gut bacteria. Fiber-rich foods—vegetables, fruits, legumes, whole grains, nuts, and seeds—promote SCFA production and support microbial diversity. Aim for a wide variety of plant foods, as different fibers feed different bacteria. If you are eating less overall on semaglutide, make each meal count by choosing nutrient- and fiber-dense options.
Increase fiber gradually to avoid bloating and gas, especially if your current intake is low. Lentils, oats, berries, broccoli, and flaxseed are excellent choices.
2. Include Fermented Foods
Fermented foods like yogurt with live cultures, kefir, sauerkraut, kimchi, and tempeh contain live microorganisms that may support gut health. While research on the direct effects of fermented foods in people taking semaglutide is limited, general evidence supports their role in promoting microbial diversity and reducing inflammation. Small portions are a good starting point if you are new to fermented foods.
3. Stay Hydrated
Constipation is a common side effect of semaglutide. Adequate hydration—along with fiber—helps maintain regular bowel movements and supports a healthy gut environment. Aim for water throughout the day, and adjust based on your activity level and climate.
Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure data4. Eat Smaller, More Frequent Meals
Because semaglutide slows gastric emptying, large meals can feel uncomfortable and worsen nausea. Smaller, more frequent meals are often better tolerated and may help you meet nutritional needs while minimizing GI distress.
5. Manage Nausea Strategically
If nausea is an issue, try bland, low-fat foods, ginger, and eating slowly. Avoid greasy or heavily spiced foods during flare-ups. If nausea persists or is severe, contact your healthcare provider—dose adjustments may be necessary.
6. Consider Probiotics—With Guidance
Probiotic supplements are widely marketed for gut health, but evidence for their use in people taking semaglutide is limited. Some people find certain strains helpful for managing GI symptoms; others see no difference. If you are interested in trying a probiotic, choose a product with documented strain specificity and discuss it with your provider. There is no single "best" probiotic for semaglutide—responses vary, and quality varies widely among products.
7. Explore Microbiome Testing for Insight
If you are curious about how your gut is responding to treatment, microbiome testing can offer a snapshot of your microbial composition. Such tests are educational tools—not diagnostic instruments—and cannot tell you definitively whether your microbiome is "healthy" or "unhealthy." But they can reveal patterns, track changes over time, and provide a starting point for personalized dietary adjustments. They are most useful when interpreted alongside symptoms, diet, and clinical context.
8. Discuss Supplement Use with Your Provider
Fiber supplements (like psyllium or methylcellulose) can help with constipation, but they should be introduced gradually and with adequate water. Some people also ask about Akkermansia supplements, which are marketed for metabolic support. While Akkermansia is a promising target, commercially available supplements vary in quality and evidence, and none are proven to replicate the effects of semaglutide. Talk to your provider before starting any supplement.
Comparing Ozempic with Other Weight Loss Medications
Semaglutide is one of several GLP-1 receptor agonists used for weight management and diabetes. Others include liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound), which is a dual GIP/GLP-1 receptor agonist. How do their microbiome effects compare?
Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure dataResearch on this question is still in its early stages, but some patterns are emerging. Studies on liraglutide have reported shifts in microbial composition similar to those seen with semaglutide—including increases in Akkermansia and changes in SCFA-producing bacteria—suggesting that microbiome modulation may be a class effect of GLP-1 receptor agonists rather than unique to semaglutide. Dulaglutide studies are fewer but point in a similar direction.
Tirzepatide, with its dual mechanism, may exert distinct effects on the gut environment because GIP receptors are also involved in nutrient sensing and gut function. Early animal data suggest that tirzepatide's microbiome effects may differ from those of pure GLP-1 agonists, but human data are limited.
The bottom line: while the magnitude and specific patterns of microbiome change may vary between medications, the general phenomenon—altered gut microbiota during GLP-1-based treatment—appears to be shared across the class. Individual responses will always vary, and more comparative research is needed.
The Future of Microbiome Science and Obesity Treatment
The intersection of microbiome science and obesity treatment is advancing rapidly. One of the most exciting—and still speculative—frontiers is the use of the microbiome as a predictor of treatment response.
Predicting Response to Treatment
A 2026 study published in Nature reported that baseline fecal microbiome composition was associated with how well individuals responded to semaglutide in terms of weight loss and glycemic improvement. In other words, certain microbial signatures at the start of treatment predicted better outcomes. If validated in larger trials, this could eventually allow clinicians to personalize treatment decisions based on a patient's microbiome profile—choosing medications or adjunctive strategies most likely to work for that individual.
This is not yet ready for clinical practice. The study is preliminary, and replication is needed. But it points toward a future where microbiome analysis becomes part of personalized obesity care.
Microbiome-Targeted Interventions
Another area of exploration is whether interventions like prebiotics, specific probiotic strains, or even fecal microbiome transplantation (FMT) could enhance the effects of GLP-1 medications or mitigate side effects. Preclinical studies suggest that manipulating the microbiome can influence GLP-1 secretion and metabolic outcomes, but human trials are scarce. FMT is currently reserved for specific clinical indications like recurrent Clostridioides difficile infection and is not a standard treatment for obesity or microbiome optimization.
Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure dataPersonalized Nutrition and Precision Medicine
As microbiome testing becomes more accessible, the concept of precision nutrition—tailoring dietary recommendations to an individual's microbiome—is gaining traction. For people on semaglutide, this could mean personalized fiber recommendations or targeted probiotic strategies based on microbial profiles. This remains an aspirational goal rather than an established standard of care, but it is a direction the field is moving toward.
Key Takeaways
- Ozempic (semaglutide) alters the composition and diversity of the gut microbiome, according to emerging research from 2024 onward.
- Some studies report reductions in overall microbial diversity during treatment, though the clinical significance of this is still being studied.
- Increases in beneficial bacteria like Akkermansia muciniphila have been observed and may contribute to improved intestinal barrier function and reduced inflammation.
- Microbiome changes are not uniform across all individuals; diet, baseline microbiome, and other factors influence how the gut responds.
- Common GI side effects like nausea and constipation are related to slowed gastric emptying, not directly to microbial changes, but the two can interact.
- Fiber-rich foods, fermented foods, adequate hydration, and smaller meals can support gut health during treatment.
- Probiotic supplements may help some people, but evidence is limited, and no single product is proven best for semaglutide users.
- Microbiome testing is an educational tool that can provide insight but cannot diagnose conditions or replace medical evaluation.
- Microbiome effects appear to be a class effect of GLP-1 receptor agonists, though specific patterns may vary between medications.
- Research into microbiome-based prediction of treatment response is promising but not yet ready for clinical use.
Frequently Asked Questions
Does Ozempic affect the gut microbiome?
Yes, research indicates that semaglutide treatment is associated with changes in the composition and diversity of gut bacteria. Studies have reported increases in certain beneficial bacteria like Akkermansia muciniphila and shifts in overall microbial diversity. These changes appear to be a real effect of the medication, though the full clinical implications are still being investigated.
Can Ozempic cause permanent gut or stomach damage?
There is no evidence that semaglutide causes permanent structural damage to the gut or stomach. The medication slows gastric emptying, which can cause symptoms like nausea and constipation, but these are typically reversible when the drug is stopped. Rare cases of gastroparesis have been reported and require medical attention, but long-term damage has not been established.
What is the best probiotic to take with semaglutide (Ozempic)?
There is no single "best" probiotic established by research for people taking semaglutide. Probiotic effects are strain-specific, and individual responses vary. If you are considering a probiotic, choose a reputable product with documented strains and discuss it with your healthcare provider. Some people find probiotics helpful for managing GI symptoms, but evidence in this specific context is limited.
What is the "poor man's Ozempic" and how does it affect the gut?
"Poor man's Ozempic" typically refers to over-the-counter supplements or natural products marketed as GLP-1 boosters, such as berberine or certain fibers. These are not equivalent to semaglutide and have far less evidence for weight loss. Some, like fiber supplements, can support gut health by feeding beneficial bacteria, but they should not be used as substitutes for prescribed medications without medical guidance.
How can I prevent or manage nausea and other GI issues on Ozempic?
Strategies include eating smaller, more frequent meals, avoiding greasy or heavily spiced foods, staying hydrated, and eating slowly. Ginger and bland foods may help with nausea. If symptoms are persistent or severe, talk to your healthcare provider—dose adjustments or other interventions may be necessary. Fiber and hydration can help with constipation.
Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure dataWhy is microbial diversity important for health?
Microbial diversity—the variety of species in the gut—is generally associated with greater resilience and better metabolic and immune function. However, diversity is not a perfect proxy for health, and reduced diversity is not automatically harmful. The relationship between diversity and health is complex and context-dependent.
Is it safe to take fiber supplements while on Ozempic?
Fiber supplements like psyllium can be safe and helpful for managing constipation, which is a common side effect of semaglutide. However, they should be introduced gradually and taken with plenty of water to avoid worsening gas or bloating. Discuss fiber supplementation with your healthcare provider, especially if you have other gastrointestinal conditions.
Do all GLP-1 medications affect the microbiome the same way?
Research suggests that microbiome changes are a class effect of GLP-1 receptor agonists, but the specific patterns may vary between medications like semaglutide, liraglutide, and dulaglutide. Tirzepatide, which also targets GIP receptors, may have distinct effects. More comparative research is needed to understand these differences fully.
Can I test my microbiome while taking Ozempic?
Yes, you can use personalized microbiome analysis while taking semaglutide to get a snapshot of your gut bacteria. Such testing is educational and can help you track changes or inform dietary choices, but it is not a diagnostic tool and should not replace medical evaluation. Results are best interpreted alongside your symptoms, diet, and clinical context.
Will my microbiome return to normal after stopping Ozempic?
It is not yet known whether microbiome changes persist after stopping semaglutide. Some studies suggest that microbial shifts may partially reverse when the medication is discontinued, but long-term data are lacking. Individual variability is likely, and more research is needed to understand the durability of these changes.
Can Ozempic improve gut health?
The answer is nuanced. Ozempic may promote certain beneficial bacteria like Akkermansia and reduce inflammation, which could be beneficial. However, it can also reduce microbial diversity in some people and cause GI side effects. Whether the net effect is "improved" gut health depends on the individual and how gut health is defined. It is not accurate to describe Ozempic as a gut health treatment.
Discover the Microbiome Test ISO-certified EU lab • Sample stays stable during shipping • GDPR-secure dataShould I take prebiotics with Ozempic?
Prebiotics—fibers that feed beneficial bacteria—are generally beneficial for gut health and can be obtained from foods like garlic, onions, bananas, and oats. Prebiotic supplements are also available. While there is no specific evidence that prebiotics enhance semaglutide's effects, a fiber-rich diet is a reasonable approach to supporting gut health during treatment. Discuss any supplement with your provider.
Conclusion
Ozempic and the gut microbiome share a complex, evolving relationship. Research clearly shows that semaglutide alters the composition of gut bacteria—sometimes in ways that may support metabolic health, and sometimes in ways that raise questions about reduced diversity and GI discomfort. What remains uncertain is how much these microbial shifts contribute to the medication's benefits or side effects, and whether they carry long-term consequences.
What is clear is that gut health is not passive. Diet, hydration, fiber intake, and lifestyle choices all influence the microbial community, and these factors are modifiable even during treatment. If you are taking Ozempic, supporting your gut with a diverse, fiber-rich diet and evidence-informed habits is a reasonable and low-risk strategy.
For those who want deeper insight, understanding your gut microbiome through testing can provide a useful snapshot—not a diagnosis, but a piece of the puzzle. Combined with guidance from your healthcare provider, this information can help you make more informed choices about your health.
Above all, remember that individual responses vary. What happens in one person's gut may not happen in another's. The science of the microbiome is still young, and humility—along with curiosity—is the right posture. If you have concerns about your gut health while on semaglutide, speak with your healthcare provider. They can help you navigate symptoms, interpret test results, and decide on the best path forward.
Keywords
ozempic microbiome, semaglutide gut health, ozempic gut bacteria, weight loss medications and microbiome, supporting gut health on GLP-1, GLP-1 receptor agonists, gut microbiota diversity, Akkermansia muciniphila, Bacteroides, Ruminococcus, metabolic health, gastric emptying, gastrointestinal side effects, nausea, constipation, cognitive function, inflammation, prebiotics, probiotics, fiber-rich foods, intestinal barrier, short-chain fatty acids, SCFAs, fecal microbiome transplantation, systematic review, clinical study, dietary intervention, gut-brain axis, immune function, weight management, type 2 diabetes treatment, microbial diversity, dysbiosis, personalized microbiome analysis